Current stock page

Catalysts

NTRA Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Diagnostics & ResearchScore data as of Sep 4, 2026

NTRA

Catalysts
Natera, Inc.
Healthcare· Medical - Diagnostics & Research
AIQ Score
NeutralAIQ Edge 5/10
Low Priority
In Line With Peers
Score data as of Sep 4, 2026
Last price
$328.18
+$0.51 (+0.16%)
Latest market quote
Momentum63
Value34
Quality57
Risk Resilience63
Sentiment75
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 5, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 52/100

Momentum 63/100 and sentiment 75/100 before the next covered event.

Recent coverage
4 articles

Updated Sep 5, 2026 · Sentiment 36.30%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 63/100AIQ Edge 5/10 In Line With Peers
Beat rate
50%
4 of 8 reported periods
Average surprise
+19.1%
Across covered historical reports
Latest result
+4.8%
Aug 6, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Aug 6, 2026-$0.49-$0.47+4.8%$661.24M$752.75M
May 7, 2026-$0.54-$0.56-3.3%$617.1M$696.64M
Feb 26, 2026-$0.51$0.35+168.4%$604.04M$665.5M
Nov 6, 2025-$0.39-$0.64-65.9%$513.45M$592.18M
Aug 7, 2025-$0.62-$0.74-20.2%$476.26M$546.6M
May 8, 2025-$0.64-$0.50+21.9%$446.23M$501.83M
Feb 27, 2025-$0.38-$0.41-7.6%$435.64M$476.06M
Nov 12, 2024-$0.57-$0.26+54.4%$361.43M$439.76M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
19
Buy
3
Hold
12-month analyst target
$303.09
-7.65% versus current price
Based on 14 analyst observations. Targets are estimates, not predictions.
Low target
$220.00
-32.96% vs latest price
Average target
$303.09
-7.65% vs latest price
High target
$375.00
+14.27% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 5, 2026

Next known earnings or reporting date.

EPS estimate-$0.22

Current analyst expectation for the upcoming report.

Revenue estimate$706.87M

Current analyst expectation for the upcoming report.

Sentiment score75

News pressure around the setup.

Momentum score63

Where event reaction would show up first.

AIQ score52/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
14
Average target
$303.09
Target upside
-7.65%
Target range
$220.00 - $375.00
90-day revisions
15

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
4
Neutral
0
Negative
0
gurufocus.com · Sep 4, 2026

Natera Inc (NTRA) CEO and President Steven Chapman Sells 1,698 Shares

Steven Chapman, CEO and President of Natera Inc (NTRA), sold 1,698 shares of the company's stock on September 1, 2026, according to a recent SEC Filing. Followi

gurufocus.com · Sep 1, 2026

NTRA Looks 47.2% Overvalued on GF Value™

On September 01, 2026, Natera Inc (NASDAQ: NTRA) announced new clinical findings published in the journal Blood Neoplasia, emphasizing the prognostic and predic

finance.yahoo.com · Aug 29, 2026

Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run?

The billionaire has good reasons to like this genetic testing leader.

gurufocus.com · Aug 28, 2026

Natera Inc (NTRA) Shares Fall 3.7% -- What GF Score of 77 Tells Investors

On August 28, 2026, Natera Inc (NTRA) shares fell 3.7%, closing at $326.26. The stock has fluctuated significantly in the past year, with a 52-week range betwee

Open full news and sentiment

NTRA Catalysts FAQ

What are the next catalysts for NTRA stock?

NTRA's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move NTRA stock?

Upcoming events that could move NTRA include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could NTRA's next earnings report affect the stock?

NTRA's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive NTRA stock higher?

NTRA could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt NTRA stock?

NTRA could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.